Nautilus Biotechnology(NAUT) - 2024 Q3 - Earnings Call Presentation

NAUTILUS" BIOTECHNOLOGY Delivering on the Promise of the Proteome OCTOBER 29, 2024 Safe harbor This presentation and the accompanying oral presentation contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, among others, statements regarding the size and growth of the protein analysis market; Nautilus Biotechnology's anticipated total addressable market; the performance, value and enabling nature of Nautilus Biotechnology's proteomics and pr ...